BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38040029)

  • 1. Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches.
    Dockery PW; DeSimone JD; Liu CK; Achuck K; Hamburger J; Bas Z; Shields CL
    Can J Ophthalmol; 2023 Nov; ():. PubMed ID: 38040029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
    Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
    Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
    Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
    Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
    BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
    Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
    Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
    Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan.
    Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA
    Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.
    Shields CL; Kaliki S; Crabtree GS; Peshtani A; Morton S; Anand RA; Coco G; Shields JA
    Cornea; 2015 Jan; 34(1):42-8. PubMed ID: 25343701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
    Augsburger JJ; Schneider S; Freire J; Brady LW
    Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results.
    Mirshahi R; Sedaghat A; Jaberi R; Azma Z; Mazloumi M; Naseripour M
    BMC Ophthalmol; 2022 Jul; 22(1):309. PubMed ID: 35842619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy in eyes with unsuspected retinoblastoma.
    Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
    Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
    Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
    Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.